Mutant E2 polypeptide (University of Bristol)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMutant E2 polypeptide (University of Bristol)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionApoptosis stimulants
TargetsUpdating
Therapy Area/IndicationsUterine Cervical NeoplasmsPapillomavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Bristol
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Bristol
Active IndicationsN/A
Inactive IndicationsUterine Cervical NeoplasmsPapillomavirus Infections

Other Information

ATC CodeN/A
Related LinksN/A